July 30th, 2014 Marathon Pharmaceuticals today announced Jeanine M. Swalec has joined the company as its vice president of regulatory affairs. Swalec, 45, most recently …
-
-
[[Whitepaper ]] Disruptive Innovation in Rare Disease Markets
-
Choosing the Right Channel Strategy for Specialty Product Success
-
[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies
-
[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches
-
What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)
